Official Title
Evaluating the Impact of COVID-19 on Research in Care Homes
Brief Summary

During the COVID-19 (corona virus) pandemic the research arena has had to rapidly adapt and change in order to facilitate and deliver research. The UK (United Kingdom) government and Public Health England have stressed the importance of such research to find solutions to treating, preventing and stopping the spread of COVID-19. Due to national and international 'lock down restrictions' delivering research in care home settings has become even more challenging. The adaptations to conducting consultations have relied heavily on the use of technology, for example video calling, telephone, email, and teleconferencing. It is suggested that the use of technology in care home settings is already a barrier to effective research delivery. Nevertheless, as care home residents are a vulnerable group, it is critical to include these groups in research in order to enable improved and evidence-based care and their access to new and emerging treatments. This study aims to assess the opinions and experiences of key stakeholders to identify barriers, and enable better facilitation of research in these settings during and post pandemic.

Detailed Description

This two phase project will use a mixed methodology.

Phase one will involve mixed methods surveys. One will be completed by care home residents
and the other will be completed by research delivery staff and care home staff.

Phase two will involve qualitative interviews with each of these groups to enable better
insight into their views and opinions on research in this area.

Completed
COVID19

Other: survey

Online survey

Other: Interview

Interview

Eligibility Criteria

Inclusion Criteria:

- Any resident of a care home in the West Midlands

- Any relative/friend of a care home resident in the West Midlands

- Any staff member or volunteer working in care home in the West Midlands

- Any researcher undertaking research in a care home in the West Midlands (during the
pandemic or proposed during the pandemic period)

Exclusion Criteria:

- Individuals who are unable to give Informed Consent

- Individuals who lack capacity

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
United Kingdom
Locations

The Royal Wolverhampton NHS Trust
Wolverhampton, United Kingdom

Kelly Hard, Principal Investigator
National Institute for Health Research, United Kingdom

The Royal Wolverhampton Hospitals NHS Trust
NCT Number
MeSH Terms
COVID-19